JENNIFER MATA: Open Payments
NPI 1831738079 · MONROE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 12 payments from 6 companies in 2025. Trend: 2023 $130 · 2024 $709 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 3 | $80 |
| Kestra Medical Technology Services, Inc. | 2 | $46 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Abbott Laboratories | 1 | $20 |
| PFIZER INC. | 1 | $16 |
Products named: LEQVIO, FARXIGA, Assure WCD, WAINUA, VERQUVO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, ELIQUIS.
Industry payments across MI — which companies pay providers there.
